| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.907 | 0.002 | 0.907 | Alcohol oxidase inhibitor | 0.157 0.009 CID_154699782 | ||
| 0.812 | 0.004 | 0.812 | Aldehyde oxidase inhibitor | |||
| 0.737 | 0.006 | 0.862 | Cholesterol antagonist | 0.862 0.003 CID_154699782 | CID_154699782 | |
| 0.712 | 0.003 | 0.712 | GABA C receptor rho-3 antagonist | |||
| 0.705 | 0.005 | 0.762 | Histamine release inhibitor | 0.762 0.004 CID_154699782 | CID_154699782 | |
| 0.687 | 0.003 | 0.687 | Peroxidase inhibitor | |||
| 0.632 | 0.007 | 0.651 | 5 Hydroxytryptamine release inhibitor | 0.651 0.006 CID_154699782 | CID_154699782 | |
| 0.626 | 0.004 | 0.626 | Calcium channel L-type activator | 0.446 0.053 CID_154699782 | ||
| 0.618 | 0.004 | 0.758 | Alpha-N-acetylglucosaminidase inhibitor | 0.758 0.002 CID_154699782 | CID_154699782 | |
| 0.609 | 0.004 | 0.609 | Anesthetic general | 0.569 0.005 CID_154699782 | ||
| 0.624 | 0.02 | 0.624 | 15-Lipoxygenase inhibitor | |||
| 0.598 | 0.016 | 0.598 | Vasodilator, peripheral | 0.522 0.024 CID_154699782 | ||
| 0.56 | 0.01 | 0.789 | Vasodilator, coronary | 0.789 0.004 CID_154699782 | CID_154699782 | |
| 0.553 | 0.009 | 0.553 | Superoxide dismutase inhibitor | |||
| 0.578 | 0.034 | 0.811 | Transcription factor NF kappa B inhibitor | 0.811 0.012 CID_154699782 | CID_154699782 | |
| 0.554 | 0.02 | 0.554 | 5 Hydroxytryptamine release stimulant | 0.481 0.03 CID_154699782 | ||
| 0.528 | 0.004 | 0.528 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.517 | 0.004 | 0.517 | Calcium channel activator | 0.306 0.086 CID_154699782 | ||
| 0.521 | 0.02 | 0.605 | Spasmolytic | 0.605 0.012 CID_154699782 | CID_154699782 | |
| 0.548 | 0.067 | 0.766 | Alpha-glucosidase inhibitor | 0.766 0.023 CID_154699782 | CID_154699782 | |
| 0.481 | 0.005 | 0.481 | Aldehyde dehydrogenase inhibitor | 0.37 0.007 CID_154699782 | ||
| 0.465 | 0.003 | 0.465 | Keratolytic | 0.095 0.034 CID_154699782 | ||
| 0.48 | 0.021 | 0.48 | Lipoxygenase inhibitor | |||
| 0.46 | 0.003 | 0.46 | Succinate dehydrogenase inhibitor | 0.219 0.036 CID_154699782 | ||
| 0.473 | 0.025 | 0.473 | 12-Lipoxygenase inhibitor | |||
| 0.5 | 0.059 | 0.5 | Caspase 9 stimulant | 0.481 0.068 CID_154699782 | ||
| 0.436 | 0.004 | 0.527 | UDP-glucose 4-epimerase inhibitor | 0.527 0.002 CID_154699782 | CID_154699782 | |
| 0.426 | 0.003 | 0.426 | GABA C receptor rho-2 antagonist | |||
| 0.418 | 0.004 | 0.418 | Histidine decarboxylase inhibitor | |||
| 0.404 | 0.004 | 0.404 | Carbonic anhydrase XV inhibitor | |||
| 0.419 | 0.02 | 0.495 | Vasodilator | 0.495 0.012 CID_154699782 | CID_154699782 | |
| 0.435 | 0.041 | 0.797 | Antithrombotic | 0.797 0.004 CID_154699782 | CID_154699782 | |
| 0.402 | 0.009 | 0.731 | Amylase inhibitor | 0.731 0.003 CID_154699782 | CID_154699782 | |
| 0.399 | 0.006 | 0.399 | Anesthetic local | |||
| 0.4 | 0.014 | 0.4 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.409 | 0.027 | 0.623 | Free radical scavenger | 0.623 0.007 CID_154699782 | CID_154699782 | |
| 0.408 | 0.026 | 0.737 | Hypoglycemic | 0.737 0.005 CID_154699782 | CID_154699782 | |
| 0.397 | 0.017 | 0.541 | Cyclic AMP phosphodiesterase inhibitor | 0.541 0.005 CID_154699782 | CID_154699782 | |
| 0.396 | 0.019 | 0.539 | Interleukin agonist | 0.539 0.007 CID_154699782 | CID_154699782 | |
| 0.408 | 0.034 | 0.682 | Antioxidant | 0.682 0.006 CID_154699782 | CID_154699782 | |
| 0.373 | 0.004 | 0.373 | Macrophage migration inhibitory factor inhibitor | |||
| 0.419 | 0.061 | 0.419 | Prostaglandin dehydrogenase inhibitor | |||
| 0.41 | 0.056 | 0.41 | Calpain 2 inhibitor | |||
| 0.369 | 0.022 | 0.369 | RNA-directed DNA polymerase inhibitor | 0.292 0.033 CID_154699782 | ||
| 0.388 | 0.041 | 0.388 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.445 | 0.099 | 0.445 | DNA directed DNA polymerase inhibitor | |||
| 0.445 | 0.103 | 0.445 | DNA polymerase beta inhibitor | |||
| 0.352 | 0.014 | 0.617 | Monophenol monooxygenase inhibitor | 0.617 0.005 CID_154699782 | CID_154699782 | |
| 0.365 | 0.029 | 0.365 | Pyruvate kinase inhibitor | |||
| 0.336 | 0.004 | 0.336 | Creatine kinase inhibitor | |||
| 0.336 | 0.004 | 0.336 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.332 | 0.006 | 0.628 | Mediator release inhibitor | 0.628 0.004 CID_154699782 | CID_154699782 | |
| 0.337 | 0.014 | 0.337 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.255 0.04 CID_154699782 | ||
| 0.357 | 0.036 | 0.357 | Sodium/bile acid cotransporter inhibitor | 0.264 0.113 CID_154699782 | ||
| 0.35 | 0.03 | 0.35 | Sigma receptor agonist | |||
| 0.316 | 0.004 | 0.316 | Toll-Like receptor 2 antagonist | 0.163 0.044 CID_154699782 | ||
| 0.313 | 0.005 | 0.313 | Porphobilinogen synthase inhibitor | |||
| 0.372 | 0.066 | 0.372 | Thyroid hormone antagonist | |||
| 0.343 | 0.037 | 0.343 | Insulysin inhibitor | |||
| 0.325 | 0.019 | 0.415 | DNA methyltransferase I inhibitor | 0.415 0.008 CID_154699782 | CID_154699782 | |
| 0.309 | 0.005 | 0.322 | Mannose-6-phosphate isomerase inhibitor | 0.322 0.004 CID_154699782 | CID_154699782 | |
| 0.311 | 0.009 | 0.311 | Cystathionine beta-synthase inhibitor | 0.251 0.015 CID_154699782 | ||
| 0.317 | 0.017 | 0.317 | Phospholipase C inhibitor | 0.223 0.032 CID_154699782 | ||
| 0.332 | 0.034 | 0.471 | DNA synthesis inhibitor | 0.471 0.015 CID_154699782 | CID_154699782 | |
| 0.316 | 0.018 | 0.316 | Lipocortins synthesis antagonist | 0.231 0.04 CID_154699782 | ||
| 0.344 | 0.047 | 0.378 | Hypoxia-inducible factor 1 alpha inhibitor | 0.378 0.036 CID_154699782 | CID_154699782 | |
| 0.296 | 0.003 | 0.296 | Ornithine decarboxylase inhibitor | 0.188 0.005 CID_154699782 | ||
| 0.295 | 0.007 | 0.295 | Adenylate kinase inhibitor | 0.215 0.013 CID_154699782 | ||
| 0.292 | 0.005 | 0.292 | GABA C receptor antagonist | |||
| 0.292 | 0.005 | 0.48 | Triose-phosphate isomerase inhibitor | 0.48 0.003 CID_154699782 | CID_154699782 | |
| 0.293 | 0.006 | 0.293 | Carbonic anhydrase VI inhibitor | 0.12 0.03 CID_154699782 | ||
| 0.299 | 0.016 | 0.299 | Insulin sensitizer | 0.274 0.023 CID_154699782 | ||
| 0.308 | 0.026 | 0.548 | Non-steroidal antiinflammatory agent | 0.548 0.005 CID_154699782 | CID_154699782 | |
| 0.34 | 0.061 | 0.547 | Apoptosis antagonist | 0.547 0.015 CID_154699782 | CID_154699782 | |
| 0.296 | 0.018 | 0.405 | NOS3 expression enhancer | 0.405 0.008 CID_154699782 | CID_154699782 | |
| 0.291 | 0.014 | 0.307 | Nitric-oxide synthase stimulant | 0.307 0.01 CID_154699782 | CID_154699782 | |
| 0.281 | 0.005 | 0.281 | TRPA1 agonist | 0.153 0.029 CID_154699782 | ||
| 0.283 | 0.007 | 0.63 | Cyclooxygenase 3 inhibitor | 0.63 0.002 CID_154699782 | CID_154699782 | |
| 0.286 | 0.016 | 0.286 | Phospholipase A2 inhibitor | 0.218 0.034 CID_154699782 | ||
| 0.297 | 0.029 | 0.41 | DNA methylase inhibitor | 0.41 0.01 CID_154699782 | CID_154699782 | |
| 0.34 | 0.072 | 0.34 | Thyroid hormone beta antagonist | |||
| 0.288 | 0.02 | 0.288 | Amyloid beta precursor protein antagonist | |||
| 0.282 | 0.016 | 0.282 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.289 | 0.023 | 0.466 | Melanin inhibitor | 0.466 0.008 CID_154699782 | CID_154699782 | |
| 0.265 | 0.005 | 0.358 | Photosensitizer | 0.358 0.003 CID_154699782 | CID_154699782 | |
| 0.263 | 0.004 | 0.263 | GABA C receptor rho-1 antagonist | |||
| 0.266 | 0.008 | 0.266 | Carbonic anhydrase XIII inhibitor | 0.244 0.009 CID_154699782 | ||
| 0.287 | 0.031 | 0.287 | Dual specificity phosphatase 3 inhibitor | |||
| 0.263 | 0.011 | 0.326 | Xanthine oxidase inhibitor | 0.326 0.006 CID_154699782 | CID_154699782 | |
| 0.261 | 0.008 | 0.261 | Carbonic anhydrase III inhibitor | 0.136 0.035 CID_154699782 | ||
| 0.336 | 0.083 | 0.336 | Thioredoxin glutathione reductase inhibitor | |||
| 0.292 | 0.039 | 0.292 | Gastrin inhibitor | 0.249 0.081 CID_154699782 | ||
| 0.263 | 0.011 | 0.582 | Expectorant | 0.582 0.003 CID_154699782 | CID_154699782 | |
| 0.252 | 0.002 | 0.252 | Granulocyte macrophage colony stimulating factor agonist | 0.084 0.063 CID_154699782 | ||
| 0.271 | 0.022 | 0.429 | Protein kinase stimulant | 0.429 0.006 CID_154699782 | CID_154699782 | |
| 0.349 | 0.102 | 0.651 | Antibacterial | 0.651 0.013 CID_154699782 | CID_154699782 | |
| 0.261 | 0.016 | 0.261 | Cholesterol synthesis inhibitor | 0.174 0.034 CID_154699782 | ||
| 0.299 | 0.054 | 0.299 | Transcription factor STAT3 inhibitor | |||
| 0.252 | 0.008 | 0.252 | Alcohol dehydrogenase inhibitor | 0.162 0.017 CID_154699782 | ||
| 0.268 | 0.025 | 0.408 | Interferon gamma antagonist | 0.408 0.01 CID_154699782 | CID_154699782 | |
| 0.268 | 0.029 | 0.285 | Neurotrophic factor enhancer | 0.285 0.022 CID_154699782 | CID_154699782 | |
| 0.245 | 0.007 | 0.245 | Mucolytic | 0.232 0.008 CID_154699782 | ||
| 0.312 | 0.075 | 0.568 | Immunostimulant | 0.568 0.021 CID_154699782 | CID_154699782 | |
| 0.256 | 0.019 | 0.256 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.31 | 0.075 | 0.31 | Streptokinase A inhibitor | |||
| 0.365 | 0.131 | 0.607 | Apoptosis agonist | 0.607 0.048 CID_154699782 | CID_154699782 | |
| 0.241 | 0.009 | 0.241 | Catalase inhibitor | |||
| 0.234 | 0.004 | 0.234 | Heat shock protein 70 antagonist | 0.228 0.004 CID_154699782 | ||
| 0.255 | 0.026 | 0.373 | Lipid peroxidase inhibitor | 0.373 0.011 CID_154699782 | CID_154699782 | |
| 0.245 | 0.016 | 0.245 | 5-Lipoxygenase inhibitor | |||
| 0.244 | 0.015 | 0.398 | ATPase inhibitor | 0.398 0.004 CID_154699782 | CID_154699782 | |
| 0.236 | 0.009 | 0.236 | Arachidonic acid antagonist | 0.188 0.045 CID_154699782 | ||
| 0.352 | 0.13 | 0.352 | Transcription factor inhibitor | |||
| 0.227 | 0.005 | 0.227 | Glutamate decarboxylase inhibitor | |||
| 0.258 | 0.036 | 0.258 | Dual specificity phosphatase inhibitor | |||
| 0.228 | 0.01 | 0.228 | Estrogen antagonist | |||
| 0.283 | 0.066 | 0.283 | Transcription factor STAT inhibitor | |||
| 0.257 | 0.041 | 0.547 | Hepatoprotectant | 0.547 0.005 CID_154699782 | CID_154699782 | |
| 0.22 | 0.005 | 0.22 | DOPA decarboxylase inhibitor | |||
| 0.23 | 0.016 | 0.23 | Ferrochelatase inhibitor | |||
| 0.246 | 0.032 | 0.246 | Protein-tyrosine phosphatase inhibitor | 0.19 0.051 CID_154699782 | ||
| 0.228 | 0.015 | 0.228 | Farnesoid X receptor antagonist | |||
| 0.222 | 0.009 | 0.414 | NADH dehydrogenase inhibitor | 0.414 0.004 CID_154699782 | CID_154699782 | |
| 0.233 | 0.021 | 0.396 | Hexokinase inhibitor | 0.396 0.004 CID_154699782 | CID_154699782 | |
| 0.263 | 0.054 | 0.27 | Psychostimulant | 0.27 0.051 CID_154699782 | CID_154699782 | |
| 0.225 | 0.017 | 0.225 | Interleukin 4 antagonist | 0.178 0.03 CID_154699782 | ||
| 0.216 | 0.008 | 0.216 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.224 | 0.018 | 0.224 | Catenin beta inhibitor | |||
| 0.273 | 0.07 | 0.273 | Aryl hydrocarbon receptor agonist | |||
| 0.206 | 0.003 | 0.206 | Glutamate (mGluR6) antagonist | 0.104 0.009 CID_154699782 | ||
| 0.216 | 0.013 | 0.261 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.261 0.009 CID_154699782 | CID_154699782 | |
| 0.207 | 0.004 | 0.21 | Glutamate release inhibitor | 0.21 0.004 CID_154699782 | CID_154699782 | |
| 0.211 | 0.009 | 0.211 | Estrogen receptor beta antagonist | |||
| 0.203 | 0.005 | 0.203 | Acyl-CoA dehydrogenase inhibitor | 0.112 0.014 CID_154699782 | ||
| 0.2 | 0.004 | 0.2 | Ca2+-transporting ATPase inhibitor | 0.189 0.005 CID_154699782 | ||
| 0.208 | 0.012 | 0.208 | Calcium antagonist | |||
| 0.199 | 0.003 | 0.199 | Aconitate hydratase inhibitor | 0.06 0.026 CID_154699782 | ||
| 0.251 | 0.056 | 0.251 | Neuropeptide Y2 antagonist | |||
| 0.204 | 0.01 | 0.204 | Glutamate dehydrogenase inhibitor | 0.122 0.022 CID_154699782 | ||
| 0.266 | 0.072 | 0.297 | DNA damaging | 0.297 0.058 CID_154699782 | CID_154699782 | |
| 0.347 | 0.154 | 0.347 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.258 | 0.066 | 0.79 | Angiogenesis stimulant | 0.79 0.004 CID_154699782 | CID_154699782 | |
| 0.227 | 0.036 | 0.227 | Heat shock protein 90 alpha antagonist | |||
| 0.2 | 0.011 | 0.2 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.253 | 0.066 | 0.394 | Hypolipemic | 0.394 0.026 CID_154699782 | CID_154699782 | |
| 0.213 | 0.029 | 0.213 | Neurotensin receptor agonist | |||
| 0.204 | 0.02 | 0.204 | GABA C receptor agonist | |||
| 0.197 | 0.015 | 0.197 | Adenylate cyclase stimulant | 0.147 0.068 CID_154699782 | ||
| 0.197 | 0.015 | 0.197 | Potassium channel (Ca-activated) activator | |||
| 0.186 | 0.005 | 0.186 | GABA aminotransferase inhibitor | 0.143 0.009 CID_154699782 | ||
| 0.219 | 0.039 | 0.219 | Cytidine deaminase inhibitor | |||
| 0.2 | 0.02 | 0.236 | Microtubule formation inhibitor | 0.236 0.012 CID_154699782 | CID_154699782 | |
| 0.2 | 0.021 | 0.2 | Aminopeptidase B inhibitor | |||
| 0.211 | 0.033 | 0.211 | Bone formation stimulant | 0.152 0.057 CID_154699782 | ||
| 0.188 | 0.011 | 0.188 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.199 | 0.022 | 0.199 | CF transmembrane conductance regulator agonist | 0.15 0.076 CID_154699782 | ||
| 0.215 | 0.039 | 0.416 | Diuretic | 0.416 0.012 CID_154699782 | CID_154699782 | |
| 0.189 | 0.015 | 0.189 | Vanilloid 1 agonist | 0.173 0.021 CID_154699782 | ||
| 0.188 | 0.014 | 0.525 | Beta glucuronidase inhibitor | 0.525 0.003 CID_154699782 | CID_154699782 | |
| 0.183 | 0.009 | 0.206 | Toll-Like receptor 4 antagonist | 0.206 0.005 CID_154699782 | CID_154699782 | |
| 0.198 | 0.025 | 0.198 | Chelator | |||
| 0.269 | 0.097 | 0.322 | Caspase 3 stimulant | 0.322 0.069 CID_154699782 | CID_154699782 | |
| 0.203 | 0.032 | 0.203 | M17 leucyl aminopeptidase inhibitor | |||
| 0.242 | 0.073 | 0.242 | Calpain inhibitor | |||
| 0.198 | 0.029 | 0.198 | DNA polymerase I inhibitor | 0.195 0.03 CID_154699782 | ||
| 0.182 | 0.014 | 0.182 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.176 | 0.008 | 0.176 | Glutathione S-transferase inhibitor | 0.097 0.04 CID_154699782 | ||
| 0.194 | 0.031 | 0.194 | Protein-tyrosine phosphatase 1B inhibitor | 0.182 0.034 CID_154699782 | ||
| 0.17 | 0.01 | 0.17 | Anabolic | 0.11 0.049 CID_154699782 | ||
| 0.202 | 0.042 | 0.202 | Acetylcholine M1 receptor antagonist | |||
| 0.165 | 0.005 | 0.165 | Transcription factor AP-1 inhibitor | 0.124 0.009 CID_154699782 | ||
| 0.161 | 0.004 | 0.161 | GABA B receptor agonist | |||
| 0.206 | 0.05 | 0.206 | Tumour necrosis factor antagonist | |||
| 0.19 | 0.037 | 0.19 | Alkaline phosphatase inhibitor | 0.189 0.037 CID_154699782 | ||
| 0.214 | 0.063 | 0.464 | Nitric oxide antagonist | 0.464 0.019 CID_154699782 | CID_154699782 | |
| 0.204 | 0.053 | 0.204 | Mcl-1 antagonist | |||
| 0.209 | 0.058 | 0.209 | P-glycoprotein inhibitor | 0.202 0.062 CID_154699782 | ||
| 0.166 | 0.015 | 0.261 | Phosphofructokinase-1 inhibitor | 0.261 0.007 CID_154699782 | CID_154699782 | |
| 0.18 | 0.03 | 0.18 | Neuropeptide Y1 antagonist | |||
| 0.158 | 0.009 | 0.158 | Biliverdin reductase inhibitor | 0.092 0.021 CID_154699782 | ||
| 0.207 | 0.058 | 0.207 | Histone acetyltransferase inhibitor | |||
| 0.221 | 0.074 | 0.221 | Interleukin antagonist | |||
| 0.149 | 0.004 | 0.149 | Estrogen-related receptor beta agonist | |||
| 0.188 | 0.044 | 0.188 | Heat shock protein 90 antagonist | |||
| 0.181 | 0.039 | 0.341 | Cell wall synthesis inhibitor | 0.341 0.008 CID_154699782 | CID_154699782 | |
| 0.148 | 0.007 | 0.148 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.122 0.011 CID_154699782 | ||
| 0.146 | 0.005 | 0.242 | Carbonic anhydrase XIV inhibitor | 0.242 0.004 CID_154699782 | CID_154699782 | |
| 0.147 | 0.007 | 0.147 | Xanthine dehydrogenase inhibitor | 0.053 0.043 CID_154699782 | ||
| 0.177 | 0.04 | 0.177 | Calcium channel blocker | |||
| 0.158 | 0.023 | 0.158 | Caspase 3 inhibitor | |||
| 0.17 | 0.035 | 0.17 | Nav1.6 sodium channel blocker | |||
| 0.176 | 0.042 | 0.176 | NADPH oxidase inhibitor | 0.129 0.073 CID_154699782 | ||
| 0.143 | 0.009 | 0.143 | Bile acid receptor antagonist | 0.099 0.052 CID_154699782 | ||
| 0.182 | 0.047 | 0.182 | Thiol protease inhibitor | |||
| 0.153 | 0.021 | 0.153 | Prolactin inhibitor | |||
| 0.142 | 0.011 | 0.142 | Calcium channel L-type blocker | |||
| 0.144 | 0.014 | 0.144 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.178 | 0.049 | 0.362 | Insulin secretagoues | 0.362 0.008 CID_154699782 | CID_154699782 | |
| 0.132 | 0.004 | 0.132 | Squalene epoxidase inhibitor | 0.067 0.015 CID_154699782 | ||
| 0.141 | 0.014 | 0.141 | Interleukin 5 antagonist | 0.121 0.023 CID_154699782 | ||
| 0.199 | 0.072 | 0.461 | Platelet adhesion inhibitor | 0.461 0.007 CID_154699782 | CID_154699782 | |
| 0.145 | 0.019 | 0.145 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.202 | 0.077 | 0.202 | Amyloid beta aggregation inhibitor | 0.141 0.115 CID_154699782 | ||
| 0.129 | 0.006 | 0.129 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.161 | 0.038 | 0.161 | Adenylate cyclase inhibitor | 0.099 0.085 CID_154699782 | ||
| 0.126 | 0.004 | 0.126 | Glutamate (mGluR group III) antagonist | |||
| 0.16 | 0.038 | 0.16 | Antibacterial (Helicobacter pylori) | |||
| 0.214 | 0.092 | 0.402 | Platelet antagonist | 0.402 0.027 CID_154699782 | CID_154699782 | |
| 0.131 | 0.009 | 0.131 | D-Ala-D-Ala ligase inhibitor | |||
| 0.245 | 0.125 | 0.442 | Interleukin 2 agonist | 0.442 0.017 CID_154699782 | CID_154699782 | |
| 0.13 | 0.01 | 0.156 | Neuraminidase (influenza) inhibitor | 0.156 0.007 CID_154699782 | CID_154699782 | |
| 0.208 | 0.089 | 0.415 | Peptidyltransferase inhibitor | 0.415 0.006 CID_154699782 | CID_154699782 | |
| 0.26 | 0.14 | 0.527 | Immunosuppressant | 0.527 0.026 CID_154699782 | CID_154699782 | |
| 0.138 | 0.018 | 0.138 | Adrenaline agonist | |||
| 0.128 | 0.01 | 0.128 | Purinergic P2X1 antagonist | 0.06 0.043 CID_154699782 | ||
| 0.122 | 0.01 | 0.122 | Beta adrenoreceptor antagonist | |||
| 0.125 | 0.013 | 0.125 | Estrogen agonist | 0.068 0.027 CID_154699782 | ||
| 0.119 | 0.008 | 0.119 | CD45 antagonist | |||
| 0.118 | 0.007 | 0.118 | Purinergic P2Y antagonist | 0.078 0.013 CID_154699782 | ||
| 0.114 | 0.004 | 0.114 | Dihydropteroate synthase inhibitor | |||
| 0.113 | 0.004 | 0.113 | Nicotinic acid receptor agonist | |||
| 0.113 | 0.005 | 0.113 | Dihydroorotase inhibitor | |||
| 0.125 | 0.017 | 0.125 | Estrogen receptor alpha antagonist | |||
| 0.134 | 0.027 | 0.134 | Electrolyte absorption antagonist | |||
| 0.117 | 0.011 | 0.162 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.162 0.008 CID_154699782 | CID_154699782 | |
| 0.144 | 0.039 | 0.144 | GABA receptor agonist | |||
| 0.111 | 0.006 | 0.111 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.189 | 0.084 | 0.189 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.118 | 0.013 | 0.118 | Carbonic anhydrase VB inhibitor | |||
| 0.113 | 0.009 | 0.113 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.122 | 0.019 | 0.122 | Aminopeptidase I inhibitor | |||
| 0.137 | 0.034 | 0.137 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.159 | 0.056 | 0.159 | Cytokine production inhibitor | |||
| 0.124 | 0.023 | 0.209 | Transcription factor NF kappa B stimulant | 0.209 0.008 CID_154699782 | CID_154699782 | |
| 0.11 | 0.012 | 0.11 | NMDA receptor glycine site agonist | |||
| 0.114 | 0.016 | 0.114 | Argininosuccinate synthase inhibitor | 0.066 0.032 CID_154699782 | ||
| 0.11 | 0.013 | 0.11 | CDC25B inhibitor | |||
| 0.101 | 0.005 | 0.101 | GABA B receptor antagonist | |||
| 0.101 | 0.005 | 0.101 | Glutamate (mGluR4) antagonist | |||
| 0.124 | 0.028 | 0.124 | ABCA1 expression enhancer | |||
| 0.103 | 0.008 | 0.103 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.104 | 0.009 | 0.104 | Leukocyte elastase inhibitor | |||
| 0.104 | 0.009 | 0.104 | Beta 1 adrenoreceptor antagonist | |||
| 0.155 | 0.061 | 0.467 | Hemostatic | 0.467 0.005 CID_154699782 | CID_154699782 | |
| 0.104 | 0.011 | 0.104 | Estrogen receptor beta agonist | |||
| 0.107 | 0.013 | 0.125 | Neuraminidase inhibitor | 0.125 0.009 CID_154699782 | CID_154699782 | |
| 0.109 | 0.016 | 0.109 | Glycine receptor agonist | 0.087 0.031 CID_154699782 | ||
| 0.143 | 0.05 | 0.275 | Alkylator | 0.275 0.014 CID_154699782 | CID_154699782 | |
| 0.129 | 0.036 | 0.141 | Acetylcholine release stimulant | 0.141 0.023 CID_154699782 | CID_154699782 | |
| 0.103 | 0.011 | 0.103 | MAP kinase kinase 7 inhibitor | |||
| 0.167 | 0.076 | 0.167 | Antipruritic | |||
| 0.248 | 0.158 | 0.248 | Beta lactamase inhibitor | |||
| 0.117 | 0.027 | 0.18 | Phosphodiesterase 6D inhibitor | 0.18 0.005 CID_154699782 | CID_154699782 | |
| 0.095 | 0.005 | 0.095 | Retinoid X receptor agonist | |||
| 0.104 | 0.015 | 0.104 | Maillard reaction inhibitor | 0.052 0.041 CID_154699782 | ||
| 0.092 | 0.005 | 0.092 | Adenine nucleotide translocase inhibitor | 0.091 0.005 CID_154699782 | ||
| 0.274 | 0.187 | 0.808 | Cyclophilin D inhibitor | 0.808 0.006 CID_154699782 | CID_154699782 | |
| 0.089 | 0.003 | 0.089 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.119 | 0.033 | 0.119 | Protein kinase C zeta inhibitor | |||
| 0.13 | 0.045 | 0.13 | Protein kinase C gamma inhibitor | |||
| 0.09 | 0.007 | 0.09 | Dihydroorotate oxidase inhibitor | |||
| 0.116 | 0.033 | 0.136 | Interleukin 12 antagonist | 0.136 0.018 CID_154699782 | CID_154699782 | |
| 0.102 | 0.019 | 0.102 | NMDA receptor agonist | |||
| 0.105 | 0.023 | 0.105 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.086 | 0.005 | 0.086 | Pregnane X receptor antagonist | |||
| 0.089 | 0.008 | 0.29 | Alpha-mannosidase inhibitor | 0.29 0.002 CID_154699782 | CID_154699782 | |
| 0.103 | 0.023 | 0.103 | HIV-1 integrase inhibitor | |||
| 0.109 | 0.03 | 0.109 | Cathepsin G inhibitor | |||
| 0.104 | 0.026 | 0.104 | Carbonic anhydrase V inhibitor | |||
| 0.124 | 0.045 | 0.347 | AMP-activated protein kinase stimulant | 0.347 0.004 CID_154699782 | CID_154699782 | |
| 0.116 | 0.037 | 0.116 | NMDA receptor antagonist | |||
| 0.119 | 0.04 | 0.119 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.118 | 0.039 | 0.144 | Uric acid excretion stimulant | 0.144 0.025 CID_154699782 | CID_154699782 | |
| 0.12 | 0.043 | 0.12 | Gastric antisecretory | |||
| 0.098 | 0.021 | 0.098 | Carbamoyl phosphate synthetase inhibitor | 0.057 0.046 CID_154699782 | ||
| 0.099 | 0.022 | 0.099 | Leukotriene antagonist | 0.078 0.034 CID_154699782 | ||
| 0.102 | 0.026 | 0.102 | CDC25A inhibitor | |||
| 0.088 | 0.013 | 0.117 | Leukotriene B4 antagonist | 0.117 0.008 CID_154699782 | CID_154699782 | |
| 0.101 | 0.026 | 0.101 | HIV-1 integrase (3'-Processing) inhibitor | 0.057 0.051 CID_154699782 | ||
| 0.101 | 0.027 | 0.101 | Peroxisome proliferator-activated receptor gamma agonist | 0.069 0.049 CID_154699782 | ||
| 0.278 | 0.204 | 0.278 | MAP kinase 1 inhibitor | |||
| 0.091 | 0.019 | 0.091 | Androgen agonist | |||
| 0.083 | 0.011 | 0.083 | Estrogen receptor alpha agonist | |||
| 0.099 | 0.027 | 0.099 | Leukotriene synthesis inhibitor | |||
| 0.091 | 0.02 | 0.091 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.1 | 0.029 | 0.149 | Interferon agonist | 0.149 0.01 CID_154699782 | CID_154699782 | |
| 0.08 | 0.009 | 0.08 | Adenosine deaminase inhibitor | 0.076 0.011 CID_154699782 | ||
| 0.129 | 0.059 | 0.129 | Acetylcholine muscarinic antagonist | |||
| 0.138 | 0.067 | 0.138 | Interleukin 1 antagonist | |||
| 0.082 | 0.011 | 0.082 | NMDA receptor subunit 3A antagonist | |||
| 0.098 | 0.028 | 0.098 | Adenosine A3 receptor antagonist | |||
| 0.115 | 0.045 | 0.121 | Sphingomyelinase inhibitor | 0.121 0.041 CID_154699782 | CID_154699782 | |
| 0.081 | 0.011 | 0.081 | Thromboxane synthase inhibitor | |||
| 0.087 | 0.017 | 0.087 | Exportin-1 inhibitor | |||
| 0.078 | 0.009 | 0.28 | Mannosidase inhibitor | 0.28 0.002 CID_154699782 | CID_154699782 | |
| 0.108 | 0.039 | 0.108 | Histamine N-methyltransferase inhibitor | |||
| 0.074 | 0.005 | 0.074 | Retinoic acid alpha receptor agonist | 0.04 0.025 CID_154699782 | ||
| 0.108 | 0.04 | 0.143 | Thioredoxin inhibitor | 0.143 0.019 CID_154699782 | CID_154699782 | |
| 0.079 | 0.012 | 0.079 | Beta 2 adrenoreceptor antagonist | |||
| 0.116 | 0.049 | 0.116 | Urease inhibitor | |||
| 0.076 | 0.01 | 0.114 | Glucose-6-phosphate isomerase inhibitor | 0.114 0.004 CID_154699782 | CID_154699782 | |
| 0.134 | 0.068 | 0.134 | Nav1.2 sodium channel blocker | |||
| 0.085 | 0.02 | 0.085 | Beta 3 adrenoreceptor antagonist | |||
| 0.121 | 0.055 | 0.121 | Calcium channel (voltage-sensitive) blocker | |||
| 0.078 | 0.013 | 0.078 | Carbonic anhydrase VII inhibitor | |||
| 0.08 | 0.015 | 0.08 | Calcium channel P-type blocker | |||
| 0.073 | 0.008 | 0.073 | Retinoid X alpha receptor agonist | |||
| 0.092 | 0.028 | 0.092 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.082 | 0.018 | 0.082 | Fatty acid synthase inhibitor | |||
| 0.088 | 0.024 | 0.088 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.136 | 0.073 | 0.136 | Neurotrophic factor | 0.117 0.101 CID_154699782 | ||
| 0.07 | 0.008 | 0.07 | RNA-directed RNA polymerase inhibitor | |||
| 0.073 | 0.012 | 0.073 | Leukotriene C antagonist | |||
| 0.089 | 0.027 | 0.089 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 CID_154699782 | ||
| 0.083 | 0.022 | 0.118 | Interferon inducer | 0.118 0.008 CID_154699782 | CID_154699782 | |
| 0.141 | 0.081 | 0.141 | MAP kinase kinase 4 inhibitor | |||
| 0.069 | 0.009 | 0.069 | Dopamine D5 agonist | |||
| 0.067 | 0.008 | 0.067 | Farnesoid X receptor agonist | |||
| 0.078 | 0.019 | 0.078 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.095 | 0.037 | 0.121 | Na+ K+ transporting ATPase inhibitor | 0.121 0.015 CID_154699782 | CID_154699782 | |
| 0.12 | 0.062 | 0.12 | Interleukin 8 antagonist | |||
| 0.125 | 0.069 | 0.125 | Cathepsin H inhibitor | |||
| 0.097 | 0.041 | 0.097 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.069 | 0.015 | 0.069 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.059 | 0.005 | 0.059 | Retinoic acid receptor agonist | 0.025 0.013 CID_154699782 | ||
| 0.061 | 0.008 | 0.061 | HCV NS5B polymerase inhibitor | |||
| 0.173 | 0.12 | 0.26 | Antiamyloidogenic | 0.26 0.067 CID_154699782 | CID_154699782 | |
| 0.192 | 0.14 | 0.192 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.095 | 0.042 | 0.095 | GABA A receptor agonist | |||
| 0.062 | 0.01 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.008 CID_154699782 | CID_154699782 | |
| 0.06 | 0.008 | 0.06 | Beta adrenoreceptor agonist | |||
| 0.123 | 0.071 | 0.123 | Nav1.3 sodium channel blocker | |||
| 0.076 | 0.025 | 0.076 | MDM2 inhibitor | |||
| 0.099 | 0.048 | 0.099 | Androgen antagonist | |||
| 0.083 | 0.032 | 0.083 | Elastase 1 inhibitor | |||
| 0.067 | 0.017 | 0.067 | Potassium channel Kv1.3 blocker | |||
| 0.07 | 0.02 | 0.07 | Beta 2 adrenoreceptor agonist | |||
| 0.083 | 0.034 | 0.083 | Carbonic anhydrase VA inhibitor | |||
| 0.145 | 0.096 | 0.251 | Interleukin 6 antagonist | 0.251 0.023 CID_154699782 | CID_154699782 | |
| 0.135 | 0.086 | 0.135 | Pregnane X receptor agonist | |||
| 0.064 | 0.015 | 0.064 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.093 | 0.044 | 0.194 | Topoisomerase II alpha inhibitor | 0.194 0.016 CID_154699782 | CID_154699782 | |
| 0.118 | 0.069 | 0.263 | Topoisomerase II inhibitor | 0.263 0.023 CID_154699782 | CID_154699782 | |
| 0.055 | 0.007 | 0.072 | Uridine phosphorylase inhibitor | 0.072 0.004 CID_154699782 | CID_154699782 | |
| 0.09 | 0.042 | 0.137 | Glycine receptor antagonist | 0.137 0.011 CID_154699782 | CID_154699782 | |
| 0.081 | 0.034 | 0.081 | Potassium channel large-conductance Ca-activated activator | |||
| 0.056 | 0.01 | 0.056 | Glutamate (mGluR3) antagonist | |||
| 0.055 | 0.009 | 0.055 | Retinoid X receptor antagonist | |||
| 0.101 | 0.055 | 0.101 | Breast cancer-resistant protein inhibitor | |||
| 0.122 | 0.076 | 0.122 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.074 | 0.029 | 0.074 | Acetylcholine M3 receptor antagonist | |||
| 0.079 | 0.035 | 0.079 | Acetylcholine M5 receptor agonist | |||
| 0.072 | 0.027 | 0.072 | Phosphodiesterase 1C inhibitor | |||
| 0.049 | 0.005 | 0.049 | Glutamate (mGluR3) agonist | |||
| 0.051 | 0.008 | 0.051 | Liver X receptor beta antagonist | |||
| 0.123 | 0.08 | 0.123 | Toll-Like receptor antagonist | |||
| 0.053 | 0.01 | 0.053 | Glutamate (mGluR8) agonist | |||
| 0.09 | 0.047 | 0.09 | Vanilloid agonist | |||
| 0.107 | 0.064 | 0.255 | Topoisomerase I inhibitor | 0.255 0.016 CID_154699782 | CID_154699782 | |
| 0.072 | 0.03 | 0.092 | Nitric oxide donor | 0.092 0.013 CID_154699782 | CID_154699782 | |
| 0.069 | 0.026 | 0.069 | Ornithine carbamoyltransferase inhibitor | |||
| 0.088 | 0.046 | 0.088 | Caspase 7 inhibitor | |||
| 0.076 | 0.034 | 0.076 | Glutamate (mGluR7) antagonist | |||
| 0.093 | 0.052 | 0.093 | Antineoplastic alkaloid | |||
| 0.049 | 0.009 | 0.049 | CF transmembrane conductance regulator antagonist | |||
| 0.054 | 0.013 | 0.054 | Angiotensin AT1 receptor antagonist | |||
| 0.059 | 0.019 | 0.059 | Cholesterol esterase inhibitor | |||
| 0.066 | 0.028 | 0.066 | GABA receptor antagonist | |||
| 0.061 | 0.023 | 0.061 | Immunoglobulin Fc receptor antagonist | |||
| 0.124 | 0.086 | 0.124 | Histone deacetylase SIRT1 inhibitor | |||
| 0.06 | 0.022 | 0.06 | Topoisomerase II beta inhibitor | 0.045 0.043 CID_154699782 | ||
| 0.056 | 0.018 | 0.056 | Kainate receptor antagonist | |||
| 0.046 | 0.009 | 0.046 | Retinoid X alpha receptor antagonist | |||
| 0.041 | 0.005 | 0.041 | Estrogen-related receptor gamma antagonist | |||
| 0.06 | 0.023 | 0.21 | Heparanase inhibitor | 0.21 0.002 CID_154699782 | CID_154699782 | |
| 0.044 | 0.008 | 0.044 | Estrogen-related receptor beta antagonist | |||
| 0.087 | 0.051 | 0.087 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.041 | 0.006 | 0.041 | Thyroid hormone agonist | |||
| 0.056 | 0.021 | 0.056 | Toll-Like receptor 2 agonist | 0.05 0.023 CID_154699782 | ||
| 0.077 | 0.042 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.047 | 0.013 | 0.047 | Leukotriene C4 antagonist | |||
| 0.074 | 0.04 | 0.074 | Protein kinase C beta inhibitor | |||
| 0.065 | 0.031 | 0.065 | Protein kinase C eta inhibitor | |||
| 0.1 | 0.066 | 0.1 | Nav1.1 sodium channel blocker | |||
| 0.049 | 0.016 | 0.049 | GABA uptake inhibitor | |||
| 0.048 | 0.015 | 0.048 | Nicotinic acid receptor 2 agonist | |||
| 0.113 | 0.08 | 0.113 | Cholinergic antagonist | |||
| 0.036 | 0.004 | 0.036 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 CID_154699782 | ||
| 0.109 | 0.076 | 0.109 | Proteasome inhibitor | |||
| 0.063 | 0.03 | 0.063 | Ryanodine receptor antagonist | |||
| 0.055 | 0.022 | 0.055 | Dopamine beta hydroxylase inhibitor | |||
| 0.058 | 0.026 | 0.158 | Phosphorylase inhibitor | 0.158 0.007 CID_154699782 | CID_154699782 | |
| 0.054 | 0.022 | 0.054 | Adenylate cyclase 1 inhibitor | |||
| 0.054 | 0.023 | 0.054 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.075 | 0.043 | 0.075 | Prostaglandin-E synthase inhibitor | |||
| 0.043 | 0.011 | 0.043 | Angiotensin II receptor antagonist | |||
| 0.041 | 0.009 | 0.041 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.065 | 0.034 | 0.065 | Heat shock protein 90 beta antagonist | |||
| 0.05 | 0.019 | 0.05 | Liver X receptor alpha agonist | |||
| 0.044 | 0.014 | 0.044 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.094 | 0.063 | 0.094 | MAO B inhibitor | |||
| 0.058 | 0.028 | 0.058 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.038 | 0.009 | 0.038 | Prostaglandin EP2 agonist | |||
| 0.047 | 0.018 | 0.047 | Calcitonin receptor agonist | |||
| 0.041 | 0.012 | 0.041 | ATP citrate lysase inhibitor | |||
| 0.061 | 0.032 | 0.061 | Thromboxane antagonist | |||
| 0.059 | 0.03 | 0.059 | NMDA 2A receptor antagonist | |||
| 0.041 | 0.012 | 0.041 | Cholesterol ester transfer protein antagonist | |||
| 0.059 | 0.031 | 0.059 | GABA A receptor antagonist | |||
| 0.061 | 0.033 | 0.075 | Lipocortins synthesis agonist | 0.075 0.017 CID_154699782 | CID_154699782 | |
| 0.044 | 0.016 | 0.044 | Fumarate hydratase inhibitor | |||
| 0.05 | 0.023 | 0.065 | Neuraminidase (Influenza A) inhibitor | 0.065 0.009 CID_154699782 | CID_154699782 | |
| 0.047 | 0.02 | 0.047 | 5-Alpha-reductase inhibitor | |||
| 0.075 | 0.049 | 0.123 | Histone deacetylase stimulant | 0.123 0.016 CID_154699782 | CID_154699782 | |
| 0.075 | 0.049 | 0.123 | Histone deacetylase SIRT1 stimulant | 0.123 0.016 CID_154699782 | CID_154699782 | |
| 0.04 | 0.013 | 0.04 | Prostaglandin agonist | |||
| 0.128 | 0.101 | 0.358 | Thrombolytic | 0.358 0.016 CID_154699782 | CID_154699782 | |
| 0.034 | 0.007 | 0.034 | Glutamate (mGluR1) agonist | |||
| 0.057 | 0.03 | 0.057 | Thromboxane A2 antagonist | |||
| 0.031 | 0.005 | 0.031 | Retinoic acid beta receptor agonist | |||
| 0.032 | 0.005 | 0.032 | Retinoic acid gamma receptor agonist | |||
| 0.052 | 0.026 | 0.052 | Aldosterone antagonist | |||
| 0.087 | 0.061 | 0.087 | Bromodomain-containing protein 2 inhibitor | |||
| 0.108 | 0.082 | 0.108 | Acetylcholine antagonist | |||
| 0.033 | 0.007 | 0.053 | Vanilloid 2 agonist | 0.053 0.003 CID_154699782 | CID_154699782 | |
| 0.108 | 0.082 | 0.108 | MAO inhibitor | |||
| 0.041 | 0.015 | 0.041 | Free fatty acid receptor 1 antagonist | |||
| 0.045 | 0.02 | 0.045 | Kainate receptor agonist | |||
| 0.133 | 0.108 | 0.133 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.092 | 0.067 | 0.092 | MAP kinase kinase 1 inhibitor | |||
| 0.05 | 0.025 | 0.05 | NMDA receptor subunit 3B antagonist | |||
| 0.047 | 0.023 | 0.047 | Glutamate (mGluR1a) antagonist | |||
| 0.034 | 0.01 | 0.135 | Sodium/glucose cotransporter 2 inhibitor | 0.135 0.002 CID_154699782 | CID_154699782 | |
| 0.041 | 0.017 | 0.041 | Sirtuin 2 inhibitor | |||
| 0.033 | 0.009 | 0.033 | Nicotinic acid receptor 2 antagonist | |||
| 0.108 | 0.085 | 0.108 | Transcription factor STAT6 inhibitor | |||
| 0.054 | 0.031 | 0.054 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.05 | 0.027 | 0.05 | Benzodiazepine antagonist | |||
| 0.035 | 0.013 | 0.035 | Elastase 2B inhibitor | |||
| 0.035 | 0.013 | 0.035 | Elastase 3B inhibitor | |||
| 0.035 | 0.013 | 0.035 | Elastase 3A inhibitor | |||
| 0.05 | 0.029 | 0.077 | Cytokine production stimulant | 0.077 0.005 CID_154699782 | CID_154699782 | |
| 0.029 | 0.009 | 0.029 | Retinoid X beta receptor agonist | |||
| 0.03 | 0.01 | 0.03 | Retinoid X gamma receptor agonist | |||
| 0.046 | 0.026 | 0.046 | Oxytocin agonist | |||
| 0.111 | 0.092 | 0.21 | DNA repair enzyme inhibitor | 0.21 0.008 CID_154699782 | CID_154699782 | |
| 0.063 | 0.044 | 0.063 | Carbonic anhydrase inhibitor | 0.06 0.046 CID_154699782 | ||
| 0.11 | 0.09 | 0.11 | Cyclooxygenase 1 inhibitor | |||
| 0.038 | 0.019 | 0.038 | Estrogen-related receptor alpha antagonist | |||
| 0.025 | 0.007 | 0.025 | Retinoid X beta receptor antagonist | |||
| 0.024 | 0.006 | 0.024 | Estrogen-related receptor gamma agonist | |||
| 0.081 | 0.063 | 0.081 | CC chemokine 5 receptor agonist | |||
| 0.029 | 0.012 | 0.143 | Sodium/glucose cotransporter inhibitor | 0.143 0.002 CID_154699782 | CID_154699782 | |
| 0.04 | 0.022 | 0.04 | Vanilloid 3 antagonist | |||
| 0.054 | 0.036 | 0.054 | Elastase inhibitor | |||
| 0.023 | 0.006 | 0.023 | Carbonic anhydrase VIII inhibitor | |||
| 0.023 | 0.006 | 0.023 | Carbonic anhydrase X inhibitor | |||
| 0.035 | 0.019 | 0.035 | Catechol O-methyltransferase inhibitor | |||
| 0.055 | 0.039 | 0.055 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.027 | 0.012 | 0.027 | Prostaglandin E2 agonist | |||
| 0.035 | 0.019 | 0.035 | Protein kinase C beta I inhibitor | |||
| 0.025 | 0.01 | 0.025 | Retinoic acid alpha receptor antagonist | |||
| 0.023 | 0.009 | 0.023 | Retinoic acid receptor antagonist | |||
| 0.06 | 0.045 | 0.06 | NMDA 2C receptor antagonist | |||
| 0.033 | 0.018 | 0.033 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.026 | 0.012 | 0.026 | Prostaglandin F2 alpha agonist | |||
| 0.088 | 0.073 | 0.088 | MAO A inhibitor | |||
| 0.072 | 0.058 | 0.085 | Phosphodiesterase VI inhibitor | 0.085 0.034 CID_154699782 | CID_154699782 | |
| 0.052 | 0.037 | 0.089 | Aldose reductase inhibitor | 0.089 0.02 CID_154699782 | CID_154699782 | |
| 0.058 | 0.044 | 0.058 | Acetylcholine M5 receptor antagonist | |||
| 0.059 | 0.045 | 0.059 | Acetylcholine M2 receptor antagonist | |||
| 0.062 | 0.048 | 0.418 | Selectin antagonist | 0.418 0.003 CID_154699782 | CID_154699782 | |
| 0.026 | 0.012 | 0.026 | Beta 1 adrenoreceptor agonist | |||
| 0.078 | 0.064 | 0.078 | Phosphodiesterase IV inhibitor | |||
| 0.025 | 0.011 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.024 0.013 CID_154699782 | ||
| 0.049 | 0.036 | 0.056 | Factor III inhibitor | 0.056 0.022 CID_154699782 | CID_154699782 | |
| 0.045 | 0.032 | 0.045 | Oleamide hydrolase inhibitor | |||
| 0.037 | 0.024 | 0.063 | Arginase inhibitor | 0.063 0.009 CID_154699782 | CID_154699782 | |
| 0.02 | 0.008 | 0.02 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.025 | 0.013 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.05 | 0.038 | 0.05 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.025 | 0.013 | 0.025 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.083 | 0.071 | 0.132 | ATPase (Vacuolar H+) inhibitor | 0.132 0.013 CID_154699782 | CID_154699782 | |
| 0.087 | 0.076 | 0.087 | Toll-Like receptor 3 antagonist | |||
| 0.02 | 0.009 | 0.02 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.028 | 0.016 | 0.028 | Calcium-sensing receptor agonist | |||
| 0.053 | 0.042 | 0.053 | Sphingosine kinase 2 inhibitor | |||
| 0.021 | 0.01 | 0.035 | Antibiotic Anthracycline-like | 0.035 0.003 CID_154699782 | CID_154699782 | |
| 0.02 | 0.009 | 0.02 | Nicotinic acid receptor 1 antagonist | |||
| 0.038 | 0.028 | 0.038 | Urate transporter 1 inhibitor | |||
| 0.033 | 0.023 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.034 | 0.024 | 0.034 | Carnitine palmitoyltransferase inhibitor | |||
| 0.049 | 0.039 | 0.097 | Carbonic anhydrase XII inhibitor | 0.097 0.02 CID_154699782 | CID_154699782 | |
| 0.059 | 0.049 | 0.059 | Heme oxygenase stimulant | |||
| 0.033 | 0.024 | 0.033 | Liver X receptor beta agonist | |||
| 0.073 | 0.065 | 0.073 | Chymotrypsin inhibitor | |||
| 0.018 | 0.011 | 0.057 | Ileal bile acid transport inhibitor | 0.057 0.003 CID_154699782 | CID_154699782 | |
| 0.042 | 0.034 | 0.042 | AICAR transformylase inhibitor | |||
| 0.031 | 0.024 | 0.031 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.033 | 0.026 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.026 | 0.02 | 0.026 | Retinoid X gamma receptor antagonist | |||
| 0.032 | 0.026 | 0.032 | Purinergic P2Y2 antagonist | |||
| 0.033 | 0.027 | 0.033 | Phosphoglycerate kinase inhibitor | |||
| 0.033 | 0.027 | 0.033 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.032 | 0.027 | 0.032 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.049 | 0.044 | 0.049 | Carbonic anhydrase I inhibitor | |||
| 0.01 | 0.005 | 0.01 | Thyroid hormone beta agonist | |||
| 0.138 | 0.133 | 0.138 | MAP kinase kinase 2 inhibitor | |||
| 0.055 | 0.05 | 0.055 | Sphingosine kinase inhibitor | |||
| 0.028 | 0.024 | 0.028 | Purinergic P2Y14 antagonist | |||
| 0.012 | 0.008 | 0.012 | Retinoic acid receptor gamma antagonist | |||
| 0.017 | 0.012 | 0.026 | Telomerase stimulant | 0.026 0.004 CID_154699782 | CID_154699782 | |
| 0.031 | 0.027 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.08 | 0.076 | 0.08 | Phosphodiesterase I inhibitor | |||
| 0.011 | 0.008 | 0.011 | Beta 3 adrenoreceptor agonist | |||
| 0.023 | 0.02 | 0.023 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.036 | 0.033 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.076 | 0.074 | 0.076 | Myeloperoxidase inhibitor | |||
| 0.011 | 0.009 | 0.011 | Retinoic acid beta receptor antagonist | |||
| 0.061 | 0.059 | 0.061 | Potassium channel (ATP-sensitive) blocker | |||
| 0.053 | 0.05 | 0.053 | Botulinum neurotoxin type A inhibitor | |||
| 0.018 | 0.017 | 0.018 | Caspase 8 inhibitor | |||
| 0.024 | 0.023 | 0.024 | Leukotriene B4 receptor 1 antagonist | |||
| 0.017 | 0.016 | 0.017 | 5-Alpha-reductase 2 inhibitor | |||
| 0.05 | 0.049 | 0.05 | Epithelial sodium channel blocker | |||
| 0.033 | 0.032 | 0.033 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.05 | 0.049 | 0.05 | Dopamine uptake inhibitor | |||
| 0.019 | 0.022 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.021 0.017 CID_154699782 | CID_154699782 | |
| 0.039 | 0.043 | 0.056 | Microtubule stabilization | 0.056 0.019 CID_154699782 | CID_154699782 | |
| 0.043 | 0.049 | 0.066 | Carbonic anhydrase IX inhibitor | 0.066 0.034 CID_154699782 | CID_154699782 | |
| 0.03 | 0.039 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.037 0.022 CID_154699782 | CID_154699782 | |
| 0.043 | 0.057 | 0.1 | Glucose-6-phosphate translocase inhibitor | 0.1 0.006 CID_154699782 | CID_154699782 | |
| 0.015 | 0.03 | 0.022 | Corticosteroid-like | 0.022 0.014 CID_154699782 | CID_154699782 | |
| 0.25 | 0.267 | 0.772 | Antiinflammatory | 0.772 0.019 CID_154699782 | CID_154699782 | |
| 0.043 | 0.06 | 0.057 | Prostaglandin EP2 antagonist | 0.057 0.044 CID_154699782 | CID_154699782 | |
| 0.006 | 0.027 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 CID_154699782 | CID_154699782 | |
| 0.017 | 0.039 | 0.056 | Squalene synthetase inhibitor | 0.056 0.013 CID_154699782 | CID_154699782 | |
| 0.021 | 0.049 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.013 CID_154699782 | CID_154699782 | |
| 0.082 | 0.116 | 0.117 | Multidrug resistance-associated protein 1 inhibitor | 0.117 0.052 CID_154699782 | CID_154699782 | |
| 0.024 | 0.079 | 0.085 | Antibiotic Aminoglycoside-like | 0.085 0.004 CID_154699782 | CID_154699782 | |
| 0.039 | 0.1 | 0.215 | Antineoplastic antibiotic | 0.215 0.019 CID_154699782 | CID_154699782 | |
| 0.011 | 0.073 | 0.024 | Dopamine D1 agonist | 0.024 0.014 CID_154699782 | CID_154699782 | |
| 0.111 | 0.176 | 0.147 | CC chemokine 6 receptor antagonist | 0.147 0.026 CID_154699782 | CID_154699782 | |
| 0.126 | 0.192 | 0.454 | Tumour necrosis factor alpha release inhibitor | 0.454 0.019 CID_154699782 | CID_154699782 | |
| 0.076 | 0.165 | 0.326 | Cell adhesion inhibitor | 0.326 0.009 CID_154699782 | CID_154699782 | |
| 0.002 | 0.093 | 0.013 | Antibiotic Macrolide-like | 0.013 0.01 CID_154699782 | CID_154699782 | |
| 0.011 | 0.103 | 0.063 | Protein 30S ribosomal subunit inhibitor | 0.063 0.005 CID_154699782 | CID_154699782 | |
| 0.029 | 0.131 | 0.106 | Factor IXa inhibitor | 0.106 0.009 CID_154699782 | CID_154699782 | |
| 0.034 | 0.146 | 0.064 | DNA gyrase inhibitor | 0.064 0.044 CID_154699782 | CID_154699782 | |
| 0.049 | 0.164 | 0.174 | Cell adhesion molecule inhibitor | 0.174 0.012 CID_154699782 | CID_154699782 | |
| 0.019 | 0.18 | 0.112 | Protein 50S ribosomal subunit inhibitor | 0.112 0.011 CID_154699782 | CID_154699782 | |
| 0.037 | 0.232 | 0.124 | DNA intercalator | 0.124 0.055 CID_154699782 | CID_154699782 | |
| 0.006 | 0.201 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 CID_154699782 | CID_154699782 | |
| 0.054 | 0.273 | 0.092 | T cell inhibitor | 0.092 0.033 CID_154699782 | CID_154699782 | |
| 0.014 | 0.242 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 CID_154699782 | CID_154699782 | |
| 0.049 | 0.304 | 0.263 | Anticoagulant | 0.263 0.036 CID_154699782 | CID_154699782 | |
| 0.036 | 0.313 | 0.082 | Falcipain 2 inhibitor | 0.082 0.067 CID_154699782 | CID_154699782 | |
| 0.037 | 0.318 | 0.085 | Falcipain inhibitor | 0.085 0.068 CID_154699782 | CID_154699782 | |
| 0.075 | 0.458 | 0.461 | Immunomodulator | 0.461 0.029 CID_154699782 | CID_154699782 | |
| 0.034 | 0.592 | 0.207 | Angiogenesis inhibitor | 0.207 0.161 CID_154699782 | CID_154699782 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |